Skip to main content

Table 5 Chemotherapeutic response according to LMR_SUV scores

From: Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy

SUV_LMR score

PR + CR

SD + PD

ORR

Compared

p value

p value

Score 0 (n = 36)

32

4

88.9%

Score 1

0.002**

< 0.001***

   

Score 2

< 0.001***

 

Score 1 (n = 57)

34

23

59.6%

Score 2

< 0.001***

 

Score 2 (n = 56)

14

42

25.0%

   
  1. SUV standardized uptake value, LMR lymphocyte-monocyte ratio, CR complete response, PR partial response, SD stable disease, PD progressive disease, ORR objective response rate. *, p < 0.05; **, p < 0.01; ***, p < 0.001
Back to article page